Pediatric Healthcare Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Global Pediatric Healthcare Market Share & Analysis. The Market is Segmented by Type (Chronic Illness and Acute Illness), Treatment (Vaccines, Drugs, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Pediatric Healthcare Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Pediatric Healthcare Market Size

Pediatric Healthcare Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 15.93 Billion
Market Size (2030) USD 19.38 Billion
CAGR (2025 - 2030) 4.00 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Pediatric Healthcare Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Pediatric Healthcare Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Pediatric Healthcare Market Analysis

The Pediatric Healthcare Market size is estimated at USD 15.93 billion in 2025, and is expected to reach USD 19.38 billion by 2030, at a CAGR of 4% during the forecast period (2025-2030).

COVID-19 had significantly impacted the pediatric healthcare market due to the decline in pediatric services during the pandemic. For instance, according to the BMC study published in March 2021, the pandemic and public health restrictions have harmed children's health and mental well-being, which has been exacerbated by the difficulties in obtaining primary and community care. The impact on children with disabilities and chronic health conditions was greater and prompted child protection concerns for vulnerable children. Such studies highlighted the adverse impact of the outbreak on pediatric healthcare in the initial phase of the pandemic, thereby impeding the market growth. However, with the surge in vaccination programs globally and the resumption of pediatric care services and facilities, the market returned to its pre-pandemic levels of growth.

The major factors attributed to the growth of the pediatric healthcare market are a growing burden of diseases, viral infections, and malnutrition cases every year. For instance, according to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. Infectious disorders such as pneumonia, diarrhea, and malaria, as well as premature birth and intrapartum complications, continue to be the primary causes of death among children under the age of five around the world. Such a high burden of deaths creates the need for early proper preventive measures which is expected to drive the growth of the market.

Furthermore, favorable government support such as funding activities, combined with increased technological advancements, fuels the pediatric healthcare market. For instance, in October 2022, French government launched "immediate action plan" along with EUR 150 million (USD 155.4 million) funding for pediatrics. Also, in June 2021, the Finance Ministry in India invested over Rs. 23,220 crore (USD 285.6 million) funding for setting up pediatric facilities in hospitals. Hence, such initiatives are likely to support market growth over the forecast period.

However, the small size of the study population and ethical issues in pediatric research, along with complications associated with medicines in pediatrics, among others, may hinder the market growth.

Pediatric Healthcare Industry Overview

The pediatric healthcare market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market such as GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc, Procter & Gamble Company, Boehringer Ingelheim, Novartis AG, and Viatris Inc. among others.

Pediatric Healthcare Market Leaders

  1. GlaxoSmithKline plc

  2. Johnson & Johnson

  3. The Procter & Gamble Company

  4. Boehringer Ingelheim

  5. Novartis AG

  6. *Disclaimer: Major Players sorted in no particular order
Pediatric Healthcare.jpg
Need More Details on Market Players and Competiters?
Download PDF

Pediatric Healthcare Market News

  • In April 2022, Gilead opened a pediatric drug development center in Ireland. The new pediatric center out of Ireland will conduct pediatric clinical trials for seven products across 18 countries.
  • In February 2022, Pfizer Inc., and BioNTech initiated a rolling submission seeking to amend the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine to include children 6 months through 4 years of age, in response to the urgent public health need in this population.

Pediatric Healthcare Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Pediatric Diseases
    • 4.2.2 Increased R&D Activities and Awareness of Pediatric Medicine Among Public
    • 4.2.3 Increasing Availability of Advanced Technologies To Provide Continuous Care
  • 4.3 Market Restraints
    • 4.3.1 Small Size of Study Population and Ethical Issues in Pediatric Research
    • 4.3.2 Complications Associated with the Medicines
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Chronic Illness
    • 5.1.2 Acute Illness
  • 5.2 By Treatment
    • 5.2.1 Vaccines
    • 5.2.2 Drugs
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Viatris
    • 6.1.3 Boehringer Ingelheim International GmbH
    • 6.1.4 Eli Lilly and Company
    • 6.1.5 Eisai Co.
    • 6.1.6 GlaxosmithklinePlc
    • 6.1.7 Gilead Sciences
    • 6.1.8 Johnson & Johnson
    • 6.1.9 Pfizer Inc
    • 6.1.10 Sanofi S A
    • 6.1.11 The Procter & Gamble Company
    • 6.1.12 Novartis International AG
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Pediatric Healthcare Industry Segmentation

As per the scope of this report, pediatric healthcare is a branch of medicine that deals with the medical care, development, and related diseases of infants, children, and adolescents. The pediatric healthcare market grows significantly as children often suffer from gastrointestinal, allergic, respiratory, and other chronic diseases owing to their lower immunity. The Pediatric Healthcare Market is Segmented by Type (Chronic Illness and Acute Illness), Treatment (Vaccines, Drugs, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Type Chronic Illness
Acute Illness
By Treatment Vaccines
Drugs
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Pediatric Healthcare Market Research FAQs

How big is the Pediatric Healthcare Market?

The Pediatric Healthcare Market size is expected to reach USD 15.93 billion in 2025 and grow at a CAGR of 4% to reach USD 19.38 billion by 2030.

What is the current Pediatric Healthcare Market size?

In 2025, the Pediatric Healthcare Market size is expected to reach USD 15.93 billion.

Who are the key players in Pediatric Healthcare Market?

GlaxoSmithKline plc, Johnson & Johnson, The Procter & Gamble Company, Boehringer Ingelheim and Novartis AG are the major companies operating in the Pediatric Healthcare Market.

Which is the fastest growing region in Pediatric Healthcare Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Pediatric Healthcare Market?

In 2025, the North America accounts for the largest market share in Pediatric Healthcare Market.

What years does this Pediatric Healthcare Market cover, and what was the market size in 2024?

In 2024, the Pediatric Healthcare Market size was estimated at USD 15.29 billion. The report covers the Pediatric Healthcare Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Pediatric Healthcare Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Pediatric Healthcare Industry Report

The pediatric healthcare market is on a trajectory of significant growth, fueled by the rising incidence of chronic and acute illnesses among children and a heightened demand for efficient treatment modalities. This growth is further bolstered by advancements in pharmaceuticals and medical devices, leading to increased demand for innovative therapies tailored for the pediatric population. With the antibiotics segment capturing a considerable market share due to the widespread prevalence of bacterial infections among children, efforts to bolster pediatric healthcare facilities globally are in full swing. North America leads this expansion, due to to its strong healthcare infrastructure, hefty R&D investments, and proactive government policies aimed at enhancing pediatric healthcare outcomes. This market's dynamism is further enriched by pediatrician companies pioneering in the field, driving innovations to cater to the health needs of children across various stages of growth. Insights from Mordor Intelligence™ highlight this market's promising outlook, underscoring the pivotal role of these companies in shaping the future of pediatric healthcare. Get a sample of this industry analysis as a free report PDF download.